Rani Therapeutics Holdings, Inc. (RANI): Price and Financial Metrics

Rani Therapeutics Holdings, Inc. (RANI): $2.31

0.02 (+0.87%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

Add RANI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#253 of 328

in industry

RANI Price/Volume Stats

Current price $2.31 52-week high $8.75
Prev. close $2.29 52-week low $1.82
Day low $2.22 Volume 432,600
Day high $2.33 Avg. volume 547,555
50-day MA $2.48 Dividend yield N/A
200-day MA $3.69 Market Cap 123.37M

RANI Stock Price Chart Interactive Chart >


Rani Therapeutics Holdings, Inc. (RANI) Company Bio


Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-103, a glucagon-like peptide-1 mimetic to treat type 2 diabetes; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was founded in 2012 and is headquartered in San Jose, California.


RANI Latest News Stream


Event/Time News Detail
Loading, please wait...

RANI Latest Social Stream


Loading social stream, please wait...

View Full RANI Social Stream

RANI Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!